Comparative Glycomics Analysis of Influenza Hemagglutinin (H5N1) Produced in Vaccine Relevant Cell Platforms
- 12 July 2013
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 12 (8) , 3707-3720
Abstract
Hemagglutinin (HA) is the major antigen in influenza vaccines, and glycosylation is known to influence its antigenicity. Embryonated hen eggs are traditionally used for influenza vaccine production, but vaccines produced in mammalian and insect cells were recently licensed. This raises the concern that vaccines produced with different cell systems might not be equivalent due to differences in their glycosylation patterns. Thus, we developed an analytical method to monitor vaccine glycosylation through a combination of nanoLC/MSE and quantitative MALDI-TOF MS permethylation profiling. We then used this method to examine glycosylation of HAs from two different influenza H5N1 strains produced in five different platforms, including hen eggs, three different insect cell lines (High Five, expresSF+ and glycoengineered expresSF+), and a human cell line (HEK293). Our results demonstrated that (1) sequon utilization is not necessarily equivalent in different cell types, (2) there are quantitative and qualitative differences in the overall N-glycosylation patterns and structures produced by different cell types, (3) ∼20% of the N-glycans on the HAs produced by High Five cells are core α1,3-fucosylated structures, which may be allergenic in humans, and (4) our method can be used to monitor differences in glycosylation during the cellular glycoengineering stages of vaccine development.Keywords
This publication has 76 references indexed in Scilit:
- Fitness costs limit influenza A virus hemagglutinin glycosylation as an immune evasion strategyProceedings of the National Academy of Sciences, 2011
- Improving influenza vaccine virus selectionReport of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14–16 June 2010Influenza and Other Respiratory Viruses, 2011
- A fast track influenza virus vaccine produced in insect cellsJournal of Invertebrate Pathology, 2011
- Distantly related plant and nematode core α1,3-fucosyltransferases display similar trends in structure–function relationshipsGlycobiology, 2011
- Glycan Shielding of the Influenza Virus Hemagglutinin Contributes to Immunopathology in MiceAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Cross-Neutralization of 1918 and 2009 Influenza Viruses: Role of Glycans in Viral Evolution and Vaccine DesignScience Translational Medicine, 2010
- Glycans on influenza hemagglutinin affect receptor binding and immune responseProceedings of the National Academy of Sciences, 2009
- Darwinian selection for sites of Asn-linked glycosylation in phylogenetically disparate eukaryotes and virusesProceedings of the National Academy of Sciences, 2009
- The detection, correlation, and comparison of peptide precursor and product ions from data independent LC‐MS with data dependant LC‐MS/MSProteomics, 2009
- Direct Ex Vivo Analyses of HLA-DR1 Transgenic Mice Reveal an Exceptionally Broad Pattern of Immunodominance in the Primary HLA-DR1-Restricted CD4 T-Cell Response to Influenza Virus HemagglutininJournal of Virology, 2007